花园生物 (300401)

Zhejiang Garden Biopharmaceutical Co.,Ltd.

ASZ

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 54346.98
  • Circulating A-Shares(W): 53461.73
  • Earnings Per Share(RMB): 0.4300
  • Net Assets Per Share(RMB): 5.8143
  • Operating Revenue(W RMB): 93570.18
  • Total Profit(W RMB): 26882.80
  • Net Profit Attributable to Parent(W RMB): 23405.94
  • Net Profit Growth Rate(%): -3.07
  • Weighted Return on Equity(%): 7.0900
  • Operating Cash Flow Per Share(RMB): 0.6350
  • Undistributed Profit Per Share(RMB): 4.4693
  • Capital Reserve Per Share(RMB): -0.0974

2. Main Business

The main business covers:

  • Vitamin Sector
  • Pharmaceutical Manufacturing Sector

3. Company Basic Information

  • Company Name: Zhejiang Garden Biopharmaceutical Co., Ltd.
  • Listing Date: 2014-10-09
  • Industry: Pharmaceutical Manufacturing
  • Address: Huayuan Village, Nanma Town, Dongyang City, Jinhua City, Zhejiang Province
  • Website: www.hybiotech.com
  • Company Profile: The company was established by the overall change of Garden Co., Ltd. into a joint stock company. On November 28, 2002, all shareholders of Garden Co., Ltd., as promoters, jointly signed the "Sponsor Agreement" for the establishment of Garden High-Tech. On December 13, 2002, Garden Co., Ltd. held a shareholders' meeting and passed a resolution to approve the overall change of Garden Co., Ltd. into a joint stock company. According to the "Audit Report" (Zhe Dong Hui Shen Zi (2002) No. 772) issued by Zhejiang Orient, the company's net assets were 52,392,787 yuan as of November 30, 2002, which were converted into 52,392,787 shares at a 1:1 ratio. On June 4, 2003, the Zhejiang Provincial Government Enterprise Listing Leading Group issued document "Zhe Shang Shi (2003) No. 42", approving the overall change of Garden Co., Ltd. into Garden High-Tech. On August 28, 2003, Zhejiang Orient issued the "Capital Verification Report" (Zhe Dong Hui Yan (2003) No. 127), confirming the total share capital of the joint stock company. On October 10, 2003, the company was registered with the Zhejiang Provincial Administration for Industry and Commerce, obtained the "Business License" with registration number 3300001010122, and the legal representative was Shao Junfang.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Zhejiang Xiangyun Technology Co., Ltd. General Legal Person 14437.64 27.01
2 Zhongke Xianxing (Beijing) Asset Management Co., Ltd. General Legal Person 500.00 0.94
3 Southern China Securities CSI 1000 ETF Fund 347.85 0.65
4 China Securities Co., Ltd. Broker 274.83 0.51
5 Hong Kong Securities Clearing Company Ltd. Northbound Capital 223.26 0.42
6 GF Trend Optimal Flexible Allocation Hybrid Securities Investment Fund Class A Fund 58.00 0.11
7 GF Henglong One-Year Holding Period Hybrid Securities Investment Fund Class A Fund 15.00 0.03
8 GF Hengyu Hybrid Securities Investment Fund Class A Fund 10.00 0.02
9 GF Jiyi One-Year Holding Period Bond Securities Investment Fund Class A Fund 10.00 0.02

5. Concept Sectors

  • Convertible Bonds
  • Vitamins
  • Synthetic Biology
  • Margin Trading & Securities Lending
  • Specialized, Sophisticated, Distinctive, and Innovative SMEs
  • ChiNext Pharmaceuticals
  • ChiNext 200

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information